Schedule 13G ownership disclosure
TITAN PHARMACEUTICALS INC D COM
Security class unavailable · CUSIP: 888314507
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001553350-22-000151
- Form type
- SC 13G
- Filer
- L1 Capital Global Opportunities Master Fund, Ltd.
- CIK
- CIK 1702202
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership